Biodegradation and utilization of quaternary alkylammonium compounds by specialized methylotrophs.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6641900)

Published in Experientia on November 15, 1983

Authors

O Ghisalba, M Küenzi

Articles by these authors

Purification and characterization of dihydrodipicolinate synthase from pea. Plant Physiol (1992) 1.17

Chemical wastes and their biodegradation--an overview. Experientia (1983) 1.13

A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. III. Isolation and identification of an early aromatic ansamycin-precursor containing the seven-carbon amino starter-unit and three initial acetate/propionate-units of the ansa chain. J Antibiot (Tokyo) (1981) 0.88

Purification and characterization of N,N-dimethylformamidase from Pseudomonas DMF 3/3. Eur J Biochem (1986) 0.86

A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. IV. Identification of 3-amino-5-hydroxybenzoic acid as a direct precursor of the seven-carbon amino starter-unit. J Antibiot (Tokyo) (1981) 0.85

Preparative 2'-reduction of ATP catalyzed by ribonucleotide reductase purified by liquid-liquid extraction. Biosci Biotechnol Biochem (2000) 0.84

3'-Demethoxy-3'-hydroxystaurosporine, a novel staurosporine analogue produced by a blocked mutant. J Antibiot (Tokyo) (1995) 0.81

Study to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. J Antibiot (Tokyo) (1990) 0.81

Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin I. J Antibiot (Tokyo) (1978) 0.81

Production of the staurosporine aglycon K-252c with a blocked mutant of the staurosporine producer strain Streptomyces longisporoflavus and by biotransformation of staurosporine with Streptomyces mediocidicus ATCC 13279. J Antibiot (Tokyo) (1995) 0.80

Purification and cDNA cloning of Xenopus laevis skin peptidylhydroxyglycine N-C lyase, catalyzing the second reaction of C-terminal alpha-amidation. Eur J Biochem (1991) 0.80

Optimization of a process for the production of (R)-2-hydroxy-4-phenylbutyric acid--an intermediate for inhibitors of angiotensin converting enzyme. J Biotechnol (1992) 0.79

3'-Demethoxy-3'-hydroxystaurosporine-O-methyltransferase from Streptomyces longisporoflavus catalyzing the last step in the biosynthesis of staurosporine. J Antibiot (Tokyo) (1998) 0.79

A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. V. Studies on the biogenetic origin of 3-substituents. J Antibiot (Tokyo) (1982) 0.78

Biodegradation and utilization of monomethyl sulfate by specialized methylotrophs. Experientia (1983) 0.77

Regulation of cephalosporin synthesis in Cephalosporium acremonium by phosphate and glucose. Arch Microbiol (1980) 0.76

Immobilization of galactosyltransferase and continuous galactosylation of glycoproteins in a reactor. Glycoconj J (1990) 0.75

Modification of recombinant N alpha-acetyl-eglin c by novel proteases from Nocardia mediterranei. Ann N Y Acad Sci (1988) 0.75

Isolation and characterization of highly (R)-specific N-acetyl-1-phenylethylamine amidohydrolase, a new enzyme from Arthrobacter aurescens AcR5b. Appl Microbiol Biotechnol (1997) 0.75

Hyphomicrobium bacterial electrode for determination of monomethyl sulfate. Biotechnol Bioeng (1985) 0.75

Preparative enzymatic synthesis of activated neuraminic acid by using a microbial enzyme. Ann N Y Acad Sci (1992) 0.75

Large scale microbial production of human interferon. Riv Biol (1983) 0.75

A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. II. Isolation and characterization of a shikimate excreting auxotrophic mutant of Nocardia mediterranei with normal rifamycin-production. J Antibiot (Tokyo) (1978) 0.75

Reaction engineering aspects of activated sugar production. CMP-Neu5Ac as an example. Ann N Y Acad Sci (1996) 0.75

A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. I. Isolation and characterization of a pentose-excreting auxotrophic mutant of Nocardia mediterranei with drastically reduced rifamycin production. J Antibiot (Tokyo) (1978) 0.75

CMP-N-acetyl neuraminic-acid synthetase from Escherichia coli: fermentative production and application for the preparative synthesis of CMP-neuraminic acid. Appl Microbiol Biotechnol (1995) 0.75

Early intermediates in the biosynthesis of ansamycins. III. Isolation and identification of further 8-deoxyansamycins of the rifamycin-type. J Antibiot (Tokyo) (1980) 0.75

D-ribulokinase from Klebsiella pneumoniae for continuous production of D-(-)-ribulose-5-phosphate. Appl Microbiol Biotechnol (1990) 0.75

Stable continuous constitutive expression of a heterologous protein in Saccharomyces cerevisiae without selection pressure. Appl Microbiol Biotechnol (1993) 0.75

Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis. J Antibiot (Tokyo) (1982) 0.75

Early intermediates in the biosynthesis of ansamycins. II. Isolation and identification of proansamycin B-M1 and protorifamycin i-M1. J Antibiot (Tokyo) (1979) 0.75

Enzyme-assisted preparation of D-tert.-leucine. Biosci Biotechnol Biochem (2001) 0.75